AdvanDx
Woburn, US · Delaware corporation · 1 known investors
Find your way into AdvanDx
Sign up to see every warm intro you have to AdvanDx
- Paths you didn't know you had: your email and LinkedIn already hold routes to the AdvanDx team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Founders & leadership
Board
DH
Dennis H. LangerBoard director
CD
Christopher D. EarlBoard director
DM
David M. RubinBoard director
LT
Lars TonnesenBoard director
HA
Hans AndreassonBoard director
HD
Heiner DreismannBoard director
TB
Thierry BernardBoard director
Investors · 1
Merck Global Health Innovation FundreportedRahway · $10M
How we know: funding news · Not right? Tell us
Reported raises · per SEC filings
Form D private placements$11.6M disclosed across 2 rounds · 2014–2015
▶$2.5MraisedMar 2015 · 2 investors · BiotechnologyRule 506(b)
▶$2.5MraisedMar 2015 · 2 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Lars TonnesenDirector
- Dennis H. LangerDirector
- Hans AndreassonDirector
- Christopher D. EarlDirector
- Donald B. HawthorneExecutive Officer
- Heiner DreismannDirector
- David M. RubinDirector
- Thierry BernardDirector
- Offering amount
- $2.5M
- Amount sold
- $2.5M
- First sale
- Feb 2015
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$9.1MraisedApr 2014 · 4 investors · BiotechnologyRule 506(b)
▶$9.1MraisedApr 2014 · 4 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Thomas P. KellyExecutive Officer
- Heiner DreismannDirector
- Hans AndreassonDirector
- Lars TonnesenDirector
- Dennis H. LangerExecutive Officer, Director
- Offering amount
- $12.1M
- Amount sold
- $9.1M
- First sale
- Mar 2014
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- Who are AdvanDx's investors?
- AdvanDx's investors include Merck Global Health Innovation Fund.
- How much funding has AdvanDx raised?
- AdvanDx has disclosed $11.6M raised across 2 rounds.
- Where is AdvanDx headquartered?
- AdvanDx is headquartered in Woburn, US.